On Tuesday the U.S. Senate Finance Committee released a report on an investigation into safety issues surrounding Avandia, a diabetes drug developed by GlaxoSmithKline. MAPLight.org reported that the drug manufacturer has given $3,388,975 to lawmakers at the federal level since 2002. In separate contributions, GlaxoSmithKline has contributed $345,959 to California state lawmakers in the same timespan. Click here to find out how much your representative has received using MAPLight.org's contribution search form.
Contributions from GlaxoSmithKline to Calif. Legislators
Jeffrey ErnstFriedman | July 14, 2010